June 8, 2017 / 5:23 AM / 2 months ago

BRIEF-Strides Shasun says gets USFDA approval for capsules indicated to treat Parkinson's disease

June 8 (Reuters) - Strides Shasun Ltd

* Says Strides Shasun receives USFDA approval for Amantadine Hydrochloride capsules

* Says product will be launched immediately

* Says Amantadine Hydrochloride capsule indicated to treat Parkinson's disease Source text: (bit.ly/2sWc08q) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below